| Fangda Partners

Alibaba on its RMB28.2 billion investment in Suning Commerce Group and Suning’s RMB14 billion investment in Alibaba.
Philips on its acquisition of the POVOS kitchen appliance business for RMB2.2 billion.
GE on its RMB3.3 billion investment in China XD Electric Co. and joint venture with XD. This was the first successful strategic investment by a U.S. Fortune 500 company in a Chinese-listed company.
Swire Beverage on its acquisition of bottling operations from The Coca-Cola Company and COFCO, also involving disposals of some bottling operations to COFCO, at a net cost of RMB4.6 billion.
The Hershey Company on its RMB2.4 billion purchase of Shanghai Golden Monkey Food Co.
Tyson Foods, Inc. in connection with the Hong Kong and China components of a deal to acquire MFG (USA) Holdings, Inc. and McKey Luxembourg Holdings.
Starbucks Corporation on its acquisition of a 50% stake in Shanghai Starbucks Coffee (a JV) for US$1.3 billion.
China Resources Enterprise on its acquisition of Tesco’s China retail business and the resulting formation of a joint venture.
Envision on its global acquisition of Automotive Energy Supply Corporation (AESC), Nissan’s worldwide car battery business, and on Envision’s joint venture with Nissan in a transaction valued at more than US$1 billion.
CITIC Group and its subsidiary CITIC Dicastal Co. on their US$300 million acquisition of KSM Castings
Tianjin Tianhai Investment Co., an A-share listed company, on its US$6 billion acquisition of Ingram Micro Inc., a NYSE-listed company.
Shanghai Electric Group on its acquisition of a 40% stake in Ansaldo Energia, a power engineering company in Italy, for €400 million.
UBS on its US$2 billion pre-IPO investment in Postal Savings Bank of China and on its US$500 million investment in the Bank of China.
The Royal Bank of Scotland, as the lead consortium investor, on the US$3.1 billion acquisition of a 10% stake in the Bank of China.
Citibank on the US$3 billion acquisition of a stake in Guangdong Development Bank.
P. Morgan Securities (Asia Pacific) on its establishment of a joint venture company in China.
China Construction Bank on its acquisition of Bankco WestLB do Brasil.
Bayer on its acquisition of Dihon Pharmaceutical Group for RMB3.6 billion.
China Everbright on its acquisition of 22.4% of the shares in LifeTech, a leading cardiovascular device manufacturer in China.
Bluesail Medical Co. on its acquisition of 93% of the shares in Biosensors International, a medical device company, for RMB5.9 billion.